Not all patients with CLL call for therapy. Inspite of all latest innovations, the iwCLL nevertheless recommends watchful observation for sufferers with asymptomatic condition.86 This recommendation relies on not less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials concl... https://brianc604rze6.tusblogos.com/profile